Start shopping and find your next favourite medicine.
Browse Catalog
Ustekinumab 45mg Injection is a prescription biologic medicine containing ustekinumab, a human monoclonal antibody that selectively targets interleukin-12 (IL-12) and interleukin-23 (IL-23). It is used for the treatment of certain immune-mediated inflammatory conditions, including moderate-to-severe plaque psoriasis and active psoriatic arthritis, according to the applicable indication and prescribing guidelines.
Ustekinumab is the active ingredient in Stelara®, the reference biologic. Ustekinumab 45mg products may be marketed under different brand names depending on the manufacturer and country.
Ustekinumab is a human monoclonal antibody that binds to the p40 protein subunit shared by IL-12 and IL-23. By inhibiting these cytokine pathways, it reduces inflammatory immune activity associated with psoriasis and psoriatic arthritis.
Ustekinumab 45mg may be prescribed for eligible patients with:
The appropriate dose and treatment interval depend on the patient’s condition, body weight, age, and the prescribing information applicable to the specific product.
Stelara® is the reference brand containing ustekinumab. Ustekinumab 45mg products may be available as biosimilars or other approved alternatives depending on the country and regulatory authorization.
For SEO purposes, the strongest primary product name is:
Ustekinumab 45mg Injection
Secondary terms such as Generic Stelara®, Stelara 45mg, Ustekinumab biosimilar, and Ustekinumab injection can be used as supporting keywords where factually appropriate.
Patients searching for Ustekinumab 45mg Injection, Buy Ustekinumab 45mg Online, Generic Stelara®, Ustekinumab 45mg Price, Ustekinumab for Psoriasis, Ustekinumab for Psoriatic Arthritis, Ustekinumab Biologic Injection, and Ustekinumab IL-12/23 Inhibitor can find prescription products through licensed pharmaceutical suppliers, subject to local prescription and regulatory requirements.
Ustekinumab 45mg is used primarily for moderate-to-severe plaque psoriasis and active psoriatic arthritis in eligible patients.
Stelara® is the reference product containing ustekinumab. Ustekinumab products may be approved as biosimilars or alternatives to Stelara® depending on the regulatory authority and specific product.
It blocks the activity of IL-12 and IL-23 by binding to their shared p40 subunit, helping reduce inflammatory immune responses.
It is administered by subcutaneous injection according to the dosing schedule prescribed by a qualified healthcare professional.
Both contain the same active ingredient, ustekinumab, but they contain different amounts of the medicine. The appropriate strength depends on the patient’s indication and other prescribing factors.
Yes. Ustekinumab is an immunomodulating biologic medicine and should be prescribed and monitored by a qualified healthcare professional.
Last Updated: August 20, 2026 | Medically Reviewed By: Licensed Pharmacist
Medical Disclaimer: This information is provided for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Ustekinumab should be used only under the supervision of a qualified healthcare professional.
Orders ship from our India Head Office within 1–2 business days of confirmation. We include full customs documentation — HS codes, certificates of origin, and pharmaceutical export permits.
Estimated delivery: 3–7 business days to UK. 7–10 business days to UAE, Saudi Arabia and Gulf countries. 10–15 days for USA and Asian countries.
All packages arrive in plain, unmarked brown boxes. No pharmacy name or medication details on the outside.
Ustekinumab 45mg Injection
Reviews
There are no reviews yet